The addition of an investigational therapeutic cancer vaccine to first-line pembrolizumab exhibited activity among patients ...
Takeda Pharmaceutical Company Limited ( NYSE: TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules October 22, 2025 9:00 AM EDT ...
Discusses 2-Year Phase II Data and AI Immunology Platform in High-Risk Melanoma October 22, 2025 10:30 AM EDTCompany ...
Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback